Standard Contracts
WARRANT TO PURCHASE COMMON STOCK OF CHAMPIONS ONCOLOGY, INC.Warrant Agreement • January 30th, 2013 • Champions Oncology, Inc. • Biological products, (no disgnostic substances)
THIS CERTIFIES that [ ] or any subsequent holder hereof (the “Holder”), has the right to purchase from CHAMPIONS ONCOLOGY, INC., a Delaware corporation (the “Company”), upon the terms and subject to the limitations on exercise and conditions hereinafter set forth, up to [ ] fully paid and nonassessable shares of the Company’s common stock, par value $0.001 per share (the “Common Stock”), subject to adjustment as provided herein, at a price per share equal to the Exercise Price (as defined below), at any time and from time to time beginning on the date on which this Warrant is originally issued (the “Issue Date”) and ending at 6:00 p.m., eastern time, on the date that is the fifth (5th) anniversary of the Issue Date (or, if such date is not a Business Day, on the Business Day immediately following such date) (the “Expiration Date”). This Warrant is issued pursuant to a Securities Purchase Agreement, dated as of [_______________] (the “Securities Purchase Agreement”). Capitalized terms u
SECURITIES PURCHASE AGREEMENTSecurities Purchase Agreement • January 30th, 2013 • Champions Oncology, Inc. • Biological products, (no disgnostic substances) • New York
SECURITIES PURCHASE AGREEMENT (this “Agreement”), dated as of January 28, 2013, by and between Champions Oncology, Inc., a Delaware corporation (the “Company”), Battery Ventures IX, L.P., a Delaware limited partnership (“Ventures”), Battery Investment Partners IX, LLC, a Delaware limited liability company (together with Ventures, “Battery”), PAR Investment Partners, L.P., a Delaware limited partnership (“PAR”) and the parties listed on the Schedule of Investors attached hereto (the “Schedule of Investors”) (each hereinafter individually referred to as an “Investor” and collectively, together with Battery and PAR unless otherwise indicated, referred to as the “Investors”).
AMENDED AND RESTATED REGISTRATION RIGHTS AGREEMENTRegistration Rights Agreement • January 30th, 2013 • Champions Oncology, Inc. • Biological products, (no disgnostic substances) • New York
This REGISTRATION RIGHTS AGREEMENT (this “Agreement”), dated as of January 28, 2013 is by and between Champions Oncology, Inc., a Delaware corporation (the “Company”), and each of the persons and entities (each referred to herein as an “Investor” and, collectively, as the “Investors”) who are signatories to the 2011 Securities Purchase Agreement (as defined below) and the 2013 Securities Purchase Agreement (as defined below), including those persons and entities whose names appear on the signature pages hereof.
